Vanda Pharmaceuticals Inc (VNDA) earnings · rev $216.1M
These earnings events as JSON? API free 100/dayVanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
This VNDA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VNDA revenue for 2025-12-31 was $216.1M. Net income was -$220.5M. Revenue was up 8.7% from 2024-12-31 to 2025-12-31. VNDA currently screens at market cap $358.4M.
When the next VNDA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VNDA research stays on the stock page; the tape stays on the quote page.
VNDA earnings FAQ
What are VNDA's latest revenue and net income?
Latest cached Vanda Pharmaceuticals Inc (VNDA) revenue for Dec 31, 2025 was $216.1M. Net income was -$220.5M. Statements: https://lician.com/financials/vnda
What is VNDA's latest diluted EPS?
Latest cached Vanda Pharmaceuticals Inc (VNDA) diluted EPS for Dec 31, 2025 was -$3.74.
What period does the latest VNDA earnings print cover?
The latest cached Vanda Pharmaceuticals Inc (VNDA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VNDA revenue change from the prior cached period?
Cached Vanda Pharmaceuticals Inc (VNDA) revenue was up 8.7% from $198.8M (Dec 31, 2024) to $216.1M (Dec 31, 2025). Statements: https://lician.com/financials/vnda
Where are VNDA earnings listed?
Cached earnings facts for Vanda Pharmaceuticals Inc (VNDA) are listed at https://lician.com/earnings/vnda. Statements: https://lician.com/financials/vnda
Not investment advice.